Consolidated Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7739072

Concept 2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
Consolidated statement of income
Statement of income
Ordinary income
Other operating income
Share of profit of entities accounted for using equity method
23,000,000 JPY
JPY
Operating revenue
7,936,000,000 JPY
9,262,000,000 JPY
Net sales
109,604,000,000 JPY
5,807,000,000 JPY
115,412,000,000 JPY
-38,000,000 JPY
115,373,000,000 JPY
119,533,000,000 JPY
119,483,000,000 JPY
114,020,000,000 JPY
5,512,000,000 JPY
-50,000,000 JPY
Cost of sales
50,847,000,000 JPY
47,360,000,000 JPY
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
320,000,000 JPY
300,000,000 JPY
Rent expenses on land and buildings
324,000,000 JPY
318,000,000 JPY
Depreciation
324,000,000 JPY
372,000,000 JPY
Operating expenses
Selling, general and administrative expenses
54,113,000,000 JPY
52,486,000,000 JPY
Operating expenses
3,223,000,000 JPY
3,209,000,000 JPY
Operating expenses
Ordinary expenses
Other operating expenses
Share of loss of entities accounted for using equity method
JPY
24,000,000 JPY
Gross profit (loss)
64,526,000,000 JPY
72,122,000,000 JPY
Operating profit (loss)
4,712,000,000 JPY
10,106,000,000 JPY
-1,000,000 JPY
10,104,000,000 JPY
308,000,000 JPY
10,413,000,000 JPY
6,053,000,000 JPY
19,421,000,000 JPY
19,636,000,000 JPY
19,608,000,000 JPY
-187,000,000 JPY
214,000,000 JPY
Ordinary profit (loss)
4,821,000,000 JPY
10,874,000,000 JPY
6,185,000,000 JPY
19,995,000,000 JPY
Net sales
General and administrative expenses
Salaries
Operating expenses
Research and development expenses
13,569,000,000 JPY
13,019,000,000 JPY
Cost of sales
Selling, general and administrative expenses
Advertising expenses
270,000,000 JPY
3,320,000,000 JPY
275,000,000 JPY
3,210,000,000 JPY
Non-operating income
Interest income
17,000,000 JPY
22,000,000 JPY
Dividend income
357,000,000 JPY
290,000,000 JPY
Other
111,000,000 JPY
217,000,000 JPY
Non-operating income
108,000,000 JPY
510,000,000 JPY
132,000,000 JPY
531,000,000 JPY
Extraordinary income
JPY
48,000,000 JPY
57,000,000 JPY
1,940,000,000 JPY
Extraordinary losses
0 JPY
1,205,000,000 JPY
12,000,000 JPY
3,120,000,000 JPY
Non-operating expenses
Interest expenses
29,000,000 JPY
17,000,000 JPY
Other
14,000,000 JPY
3,000,000 JPY
Non-operating expenses
49,000,000 JPY
172,000,000 JPY
Profit (loss) before income taxes
4,821,000,000 JPY
9,716,000,000 JPY
6,230,000,000 JPY
18,815,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of non-current assets
44,000,000 JPY
1,881,000,000 JPY
Gain on sale of investment securities
JPY
3,000,000 JPY
57,000,000 JPY
59,000,000 JPY
Income taxes - current
120,000,000 JPY
1,597,000,000 JPY
25,000,000 JPY
5,191,000,000 JPY
Extraordinary losses
Loss on sale of investment securities
JPY
JPY
11,000,000 JPY
11,000,000 JPY
Income taxes - deferred
-253,000,000 JPY
814,000,000 JPY
5,000,000 JPY
-15,000,000 JPY
Income taxes
-133,000,000 JPY
2,411,000,000 JPY
30,000,000 JPY
5,175,000,000 JPY
Profit (loss)
4,954,000,000 JPY
4,954,000,000 JPY
4,954,000,000 JPY
4,954,000,000 JPY
7,305,000,000 JPY
6,199,000,000 JPY
6,199,000,000 JPY
6,199,000,000 JPY
6,199,000,000 JPY
13,639,000,000 JPY
Profit (loss) attributable to owners of parent
7,305,000,000 JPY
7,305,000,000 JPY
7,305,000,000 JPY
13,639,000,000 JPY
13,639,000,000 JPY
13,639,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-2,732,000,000 JPY
2,591,000,000 JPY
Foreign currency translation adjustment
-45,000,000 JPY
-7,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
5,000,000 JPY
-17,000,000 JPY
Remeasurements of defined benefit plans, net of tax
781,000,000 JPY
-3,407,000,000 JPY
Other comprehensive income
-1,990,000,000 JPY
-841,000,000 JPY
Profit attributable to
Comprehensive income
5,315,000,000 JPY
12,798,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
5,315,000,000 JPY
12,798,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.